Ulrik Bjørn Andersen

Medicine & Life Sciences

1. Hypertension 100%
2. Glucagon-Like Peptide 1 74%
3. Natriuretic Peptides 73%
4. Exenatide 70%
5. Blood Pressure 66%
6. Glucagon-Like Peptide-1 Receptor 64%
7. Perfusion 63%
8. Kidney 61%
9. Placebos 54%
10. Renal Artery Obstruction 54%
11. Cross-Over Studies 47%
12. Glucagon-Like Peptide 2 47%
13. Losartan 45%
14. Renal Artery 44%
15. copeptins 43%
16. Angiotensin II 36%
17. Serum 36%
18. Obesity 35%
19. Arteries 35%
20. Antipsychotic Agents 34%
21. Potassium 34%
22. Magnetic Resonance Imaging 33%
23. Renin-Angiotensin System 32%
24. Albuminuria 32%
25. Insulin Resistance 31%
26. Arginine Vasopressin 30%
27. Bone Remodeling 29%
28. Biomarkers 27%
29. (E)-N-(3-iodoprop-2-enyl)-2beta-carbofluoroethoxy-3beta-(4'-methyl-phenyl) nortropane 27%
30. Atrial Natriuretic Factor 25%
31. Fats 24%
32. Chronic Renal Insufficiency 23%
33. Body Mass Index 23%
34. Bone and Bones 22%
35. Albumins 22%
36. Type 1 Diabetes Mellitus 22%
37. human ADIPOQ protein 21%
38. Glucose 21%
39. Weights and Measures 21%
40. Body Composition 20%
41. Troleandomycin 19%
42. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 19%
43. Multiparametric Magnetic Resonance Imaging 19%
44. Healthy Volunteers 19%
45. Pulmonary Edema 19%
46. Urine 18%
47. Type 2 Diabetes Mellitus 18%
48. Insulin 18%
49. Hormones 18%
50. Compliance 18%